Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH242965Aexternal-prioritypatent/CH457420A/de
Application filed by Ciba Geigy AG, Ciba AGfiledCriticalCiba Geigy AG
Priority to FR49615ApriorityCriticalpatent/FR1468238A/fr
Application grantedgrantedCritical
Publication of FR1468238ApublicationCriticalpatent/FR1468238A/fr
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
FR49615A1965-02-221966-02-15Procédé pour la préparation du 3-oxo-7alpha-méthyl-17-éthylènedioxy-delta1, 4-androstadiène
ExpiredFR1468238A
(fr)